logo
Plus   Neg
Share
Email

Myriad Genetics Inc. Q3 adjusted earnings Miss Estimates

Below are the earnings highlights for Myriad Genetics Inc. (MYGN):

-Earnings: -$115.2 million in Q3 vs. $6.9 million in the same period last year.
-EPS: -$1.55 in Q3 vs. $0.09 in the same period last year.
-Analysts projected $0.02 per share
-Revenue: $164.0 million in Q3 vs. $216.6 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT